Biotime Inc., 10% Owner at OncoCyte Corp (OCX), sold 2,250,000 shares at $2.00 ($4.5M) on 2019-07-05, disclosed to the SEC on 2019-07-05.
Open-market sale of $4.5M OCX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.